Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LaFleur Advancing Restart of Beacon Gold Mill and Bulk Sample for Swanson Project (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Dri Healthcare Trust
T.DHT.UN
Alternate Symbol(s):
DHTRF
Healthcare
Biotechnology
DRI Healthcare Trust is a Canada-based company engaged in global pharmaceutical royalty monetization. The Company is involved in pharmaceutical royalty monetization and provides capital to inventors, academic institutions and biopharma companies. It acquires more than 25 royalties on 20-plus drugs, including Eylea, Orserdu, Omidria, Spinraza, Stelara, Vonjo, Zejula and Zytiga. Its portfolio...
includes Empaveli/Syfovre, Eylea I, Eylea II, Ilaris, Natpara, Omidria, Oracea, Orserdu I, Orserdu II, Rydapt, Simponi, Spinraza, Stelara, Vonjo I, Vonjo II, Xenpozyme, Xolair, Zejula, Zytiga, sebetralstat, and others. Its therapeutic areas include hematology, ophthalmology, influenza, endocrinology, dermatology, oncology, neurology, immunology, lysosomal storage disorder, hereditary angioedema, and others. The Company is managed by DRI Capital Inc. Its products are marketed by pharmaceutical companies, including Regeneron, Bayer, Santen; AstraZeneca; Takeda; Galderma Laboratories; and others.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:DHT.UN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(12)
•••
raybay_98
X
Post by
raybay_98
on Nov 06, 2024 12:07pm
My My
No suckers to be had! jmho
(12)
•••
raybay_98
X
Comment by
raybay_98
on Nov 05, 2024 3:29pm
RE:CIBC Report
Looks like the 'rats' are leaving the sinking ship! jmho
(6293)
•••
retiredcf
X
Post by
retiredcf
on Nov 05, 2024 9:03am
CIBC Report
EQUITY RESEARCH November 4, 2024 Earnings Update DRI HEALTHCARE TRUST Evolving The Approach – Acquiring A Royalty On Sebetralstat Our Conclusion DRI is acquiring a royalty on worldwide net sales of
...more
(23)
•••
HermannHaller
X
Comment by
HermannHaller
on Nov 05, 2024 8:50am
RE:Upgrades happening this am...
CIBC note: https://x.com/TSXDivStock/status/1853789828925587657
(6293)
•••
retiredcf
X
Post by
retiredcf
on Nov 05, 2024 8:31am
RBC Report
Their upside scenario target is now $21.00. GLTA November 4, 2024 Outperform TSX: DHT-U; CAD 14.03 Price Target CAD 17.00 ↑ 16.00
...more
(7)
•••
sunshine7
X
Post by
sunshine7
on Nov 05, 2024 8:05am
Upgrades happening this am...
CIBC’s Scott Fletcher moved his target for DRI Healthcare Trust (DHT-UN-T +1.52%increase) to $19.50 from $18.50 with an “outperformer” rating, while RBC’s Douglas Miehm increased his target to $17
...more
(32)
•••
junglejames
X
Comment by
junglejames
on Nov 04, 2024 4:12pm
RE:RE:Not everyone like new management's approach
SoF: I think this is positive too, but I've long given up trying to anticipate how the market will react in the short term. Today, I also thought that Bell freezing the dividend and stepping into
...more
(23)
•••
HermannHaller
X
Comment by
HermannHaller
on Nov 04, 2024 2:53pm
RE:RE:Not everyone like new management's approach
The $5mm relative to assets of over $1 billion is not significant, but KALV is up almost 12% already, so good start.
(70)
•••
SONOFFERGUS
X
Comment by
SONOFFERGUS
on Nov 04, 2024 1:00pm
RE:Not everyone like new management's approach
Hey junglejames. Yeah, I saw this cross. I always wonder whether they give us any info -- is someone trying to paint a picture for algos? Obviously, block trades happen at a
...more
(32)
•••
junglejames
X
Post by
junglejames
on Nov 04, 2024 12:06pm
Not everyone like new management's approach
The first step away from a strictly royalty enterprise to taking an equity share in the patent owners doesn't apparently suit everyone. Achieving greater returns requires taking on a
...more
(6293)
•••
retiredcf
X
Post by
retiredcf
on Nov 04, 2024 11:30am
RBC
This should not be in the red; potential here for RBC to raise their current target. GLTA November 4, 2022 DRI Healthcare Trust Acquires synthetic royalty interest in long
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Nov 04, 2024 7:06am
New Press Release - DRI Healthcare Trust Announces Acquisition of a Synthetic Royalty Interest in the Worldwide Sales of Sebetralstat for the Treatment of Hereditary Angioedema Plus an Equity Investment in KalVista Pharmaceuticals
– First pre-approval royalty acquisition and first equity investment highlight evolving investment strategy –– Up to US$184 million investment brings capital deployment to over US$1 billion since IPO –– Long-term asset in new therapeutic area further increases portfolio duration and...
read article.
(1462)
•••
Red_Deer
X
Post by
Red_Deer
on Nov 01, 2024 10:26pm
RayBay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Hey RayBay__WHAT GIVES eh ???? We Have NOT SEEN You on the Chemtrade Board For 2 MONTHS NOW eh !!!! Comment by raybay_98on Sep 05, 2024 11:11am 69 Views Post
...more
(12)
•••
raybay_98
X
Comment by
raybay_98
on Nov 01, 2024 11:45am
RE:RE:RE:RE:Back in Business
Yes, it's called DHT.UN! jmho
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
ReGen III: Pioneering a Cleaner Lubricants Future with Patented Re-Refining
Have you held units of a TD mutual fund through a discount broker? Learn more.